🧔♂️ A friendly human may check it before it goes live. More news here
Israeli startups raise $15.6b in 2025 as AI deals dominate: report
Israeli startups raised US$15.6 billion in 2025, driven by larger and more concentrated investments in AI, according to preliminary data from Startup Nation Central.
The year saw fewer fundraising rounds, with only 717 completed—the lowest in a decade—but nearly half of the total capital went into deals over US$100 million.
Enterprise software, particularly AI applications, led fundraising with US$4.5 billion, while cybersecurity followed at US$4.1 billion and recorded a median deal size of US$20 million.
🔗 Source: Calcalist
🧠 Food for thought
Implications, context, and why it matters.
Cybersecurity’s outsized returns mask a narrowing investment landscape
- Cybersecurity raised $4.1 billion with a $20 million median deal size per Startup Nation Central preliminary 2025 data. It made up 58% of M&A value in Q3 2025, led by Palo Alto Networks’ $25 billion purchase of CyberArk (an identity-security company) 1.
- Investors now crowd into cyber because exits look predictable. In H1 2025, health tech and life sciences raised $630 million 2. For the year, healthcare posted the most deals at 152, which signals many small bets.
- Israel’s tech ecosystem now leans on one sector’s mergers and acquisitions (M&A) appetite. Cybersecurity delivers exits, while areas like health tech stay capital-starved despite deals.
Cloud and data infrastructure providers can target Israel’s 1,000 early-stage deep-tech firms
- About 1,000 early-stage deep-tech companies operate in Israel (startups built on science or engineering-heavy innovation), and 120 have raised over $100 million 3. Many AI and medical tech teams now need scalable infrastructure.
- Healthcare logged 152 rounds in 2025, the most 4. Immunai (an AI-driven immunology platform; $313 million raised) pairs well with cloud partners that offer Health Insurance Portability and Accountability Act (HIPAA)-compliant computing plus data management 4. Sight Diagnostics (blood-testing technology; $186.8 million raised) is another fit 4.
- Enterprise software vendors and Application Programming Interface (API) providers can move early because the median fundraising cycle from seed to Series A (the first major venture round) hit 35 months, which gives infrastructure partners a longer window to embed solutions before companies scale 2.
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.




